Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
FDC | NSE
7.20
2.24%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
01/04/2026
328.30
325.50
333.65
325.50
FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments including anti-infective gastrointestinal ophthalmological vitamins/minerals/dietary supplements cardiac anti-diabetes respiratory gynaecology dermatology analgesics and others; and oral rehydration salts. It provides specialized formulations primarily under the Zifi Electral Enerzal Vitcofol Pyrimon Zocon Zoxan Zathrin Zipod Zefu Cotaryl and Mycoderm brand names. The company also offers anti-oxidants balanced energy drinks and vitamins and nutraceuticals under the Enerzal Humyl Mum Mum 1 Prosoyal Simyl-LBW Simyl-MCT and Zefrich brands. In addition it provides various active pharmaceutical ingredients. The company was founded in 1936 and is headquartered in Mumbai India.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
Price Below SMA10D
Smallcap (300M - 2B USD)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
23.1%1 month
31.0%3 months
30.7%6 months
30.1%28.02
-
4.24
0.01
0.01
19.21
4.36
-
3.64B
54.17B
581.30M
-
21.24
10.40
19.00
14.96
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
35.05
Range1M
72.05
Range3M
115.05
Rel. volume
0.45
Price X volume
19.65M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Aarti Pharmalabs Limited | AARTIPHARM | Drug Manufacturers-Specialty & Generic | 635.05 | 57.55B | 7.28% | 24.57 | 16.23% |
| Supriya Lifescience Limited | SUPRIYA | Biotechnology | 601 | 48.20B | 6.96% | 32.96 | 0.67% |
| Sun Pharma Advanced Research Company Limited | SPARC | Drug Manufacturers-Specialty & Generic | 120.34 | 39.05B | 4.74% | n/a | 48.63% |
| Shilpa Medicare Limited | SHILPAMED | Drug Manufacturers-Specialty & Generic | 374.7 | 37.00B | 7.39% | 172.28 | 51.83% |
| Suven Life Sciences Limited | SUVEN | Drug Manufacturers-Specialty & Generic | 147.43 | 32.58B | 11.94% | n/a | 0.26% |
| Aarti Drugs Limited | AARTIDRUGS | Drug Manufacturers-Specialty & Generic | 346.4 | 31.66B | 8.33% | 27.18 | 44.03% |
| RPG Life Sciences Limited | RPGLIFE | Drug Manufacturers-Specialty & Generic | 1877.6 | 31.07B | 1.07% | 50.00 | 0.00% |
| Gufic Biosciences Limited | GUFICBIO | Drug Manufacturers-Specialty & Generic | 288.7 | 28.96B | 5.44% | 50.00 | 62.51% |
| ZOTA | ZOTA | Biotechnology | 1116.2 | 28.94B | 4.83% | n/a | 105.90% |
| Orchid Pharma Limited | ORCHPHARMA | Drug Manufacturers-Specialty & Generic | 519.3 | 26.44B | 7.64% | 59.92 | 11.56% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Vertoz Advertising Limited | VERTOZ | Advertising Agencies | 31.14 | 27.32B | 10.46% | 48.67 | 10.74% |
| "SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 101.34 | 14.93B | 12.25% | 28.83 | 43.67% |
| Signpost India Limited | SIGNPOST | Advertising Agencies | 231.11 | 13.55B | 4.36% | 30.54 | 80.30% |
| V2 Retail Limited | V2RETAIL | Apparel Retail | 189.42 | 6.76B | 0.17% | 120.49 | 191.28% |
| Bhagyanagar India Ltd | BHAGYANGR | Copper | 151.06 | 4.88B | 9.69% | 36.36 | 52.08% |
| Madhav Copper Limited | MCL | Copper | 57.49 | 1.59B | 4.99% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 83.8 | 1.22B | 13.34% | 35.85 | 21.78% |
| Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 65.89 | 734.59M | 4.50% | 50.06 | 4.88% |
| Sagardeep Alloys Limited | SAGARDEEP | Copper | 22.89 | 397.37M | 3.95% | 58.62 | 43.14% |
| Heads UP Ventures Limited | HEADSUP | Apparel Retail | 6.92 | 151.62M | 14.38% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 19.21 | 24.85 | Cheaper |
| Ent. to Revenue | 4.36 | 11.40 | Cheaper |
| PE Ratio | 28.02 | 51.36 | Cheaper |
| Price to Book | 4.24 | 6.83 | Cheaper |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 30.67 | 42.17 | Lower Risk |
| Debt to Equity | 0.01 | 0.35 | Cheaper |
| Debt to Assets | 0.01 | 0.17 | Cheaper |
| Market Cap | 54.17B | 290.82B | Emerging |